Vesicular Transport Mechanisms in Centrosome Regulation and Ciliogenesis
Project Number5R01GM133915-02
Contact PI/Project LeaderCAPLAN, STEVEN H
Awardee OrganizationUNIVERSITY OF NEBRASKA MEDICAL CENTER
Description
Abstract Text
Centrosomes are microtubule nucleating and organizing organelles that directly affect the interphase
microtubule array, mitotic spindles and cilia. Despite their significance in development and linkage to
diseases such as cancer, ciliopathies and birth defects, fundamental aspects of centrosome function and
duplication remain poorly understood. For example, some proteins within the organelle act as barriers to its
duplication while others inhibit the assembly of cilia, and, thus, must be eliminated at specific points in the
cell cycle to enable the step-wise progression of these events. At present, it is assumed that diffusion
accounts for the exchange of most centrosomal proteins. However, trafficking of centrosomal proteins
toward or away from centrosomes is a plausible but relatively unexplored mechanism for controlling
centrosome duplication and ciliogenesis. Previously, we showed that the endocytic regulatory protein,
EHD1, is a regulator of ciliogenesis by mediating the fusion of distal appendage vesicles on centrosomes
to form the ciliary vesicle. Our data support an additional role for EHD1 in controlling the centrosome
duplication cycle, by promoting the redistribution of Cep215, CP110 and pericentrin (PCNT) from
centrosomes to the spindle midbody during mitosis, effectively removing these protein barriers of
centrosome duplication. Our findings also implicate several EHD1-interacting partners, including the
retromer and MICAL-L1. Remarkably, we now find that MICAL-L1 is anchored to the centrosome/centrioles
by binding to tubulins, highlighting the possibility that it may serve as a recruiter of EHD1 to the
centrosome. The objective of this application is to determine whether vesicular trafficking is a novel
fundamental regulator of the centrosome duplication cycle and cilia formation. Our central hypothesis is
that the EHD1/MICAL-L1/retromer recycling complex promotes a vesicular transport mechanism to strip
specific regulatory proteins from centrosomes, thereby enabling key steps in centrosome duplication and
ciliogenesis. Our specific aims are: 1.) Elucidate the mechanism by which endocytic vesicles remove
centriolar and PCM proteins from centrosomes. We hypothesize that EHD1 (present of the cytoplasmic
face of endocytic vesicles) docks with the distal appendages of centrioles, potentially via MICAL-L1,
interacts with centriolar protein CP110 and PCM proteins Cep215 and PCNT, and facilitates the
redistribution of these regulatory proteins to the spindle midbody as vesicular cargo. 2.) Interrogate the
mechanisms by which EHD1 and its endocytic interaction partners regulate ciliogenesis. We will test the
hypothesis that a EHD1/MICAL-L1/retromer complex coordinate the steps leading to ciliogenesis. Impact:
Understanding the mechanisms of these processes forges a novel link between endocytic trafficking and
centrosome biology, and will guide future studies to explore the etiology of centrosome dysfunction during
tumorigenesis and ciliopathy.
Public Health Relevance Statement
Project Narrative
Despite its significance during development and the direct linkage between the
centrosome and numerous diseases (including cancer and ciliopathies), key aspects of
centrosome function and duplication remain poorly understood. The knowledge to be
gained from undertaking this proposal will lead to a significantly enhanced understanding
of the mechanisms by which centrosomes duplicate and cilia are generated, and will
have an important bearing on health and disease.
No Sub Projects information available for 5R01GM133915-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM133915-02
Patents
No Patents information available for 5R01GM133915-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM133915-02
Clinical Studies
No Clinical Studies information available for 5R01GM133915-02
News and More
Related News Releases
No news release information available for 5R01GM133915-02
History
No Historical information available for 5R01GM133915-02
Similar Projects
No Similar Projects information available for 5R01GM133915-02